↓ Skip to main content

Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing

Overview of attention for article published in JAMA: Journal of the American Medical Association, June 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

news
2 news outlets
blogs
1 blog
twitter
251 X users
facebook
4 Facebook pages

Readers on

mendeley
77 Mendeley
Title
Direct-to-Consumer Genetic Testing: The Implications of the US FDA’s First Marketing Authorization for BRCA Mutation Testing
Published in
JAMA: Journal of the American Medical Association, June 2018
DOI 10.1001/jama.2018.5330
Pubmed ID
Authors

Jennifer Gill, Adam J. Obley, Vinay Prasad

X Demographics

X Demographics

The data shown below were collected from the profiles of 251 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 19%
Student > Master 14 18%
Student > Ph. D. Student 6 8%
Other 5 6%
Professor 3 4%
Other 12 16%
Unknown 22 29%
Readers by discipline Count As %
Medicine and Dentistry 17 22%
Biochemistry, Genetics and Molecular Biology 13 17%
Nursing and Health Professions 5 6%
Social Sciences 4 5%
Agricultural and Biological Sciences 2 3%
Other 7 9%
Unknown 29 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 162. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2019.
All research outputs
#256,841
of 25,793,330 outputs
Outputs from JAMA: Journal of the American Medical Association
#3,333
of 36,825 outputs
Outputs of similar age
#5,476
of 342,802 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#74
of 341 outputs
Altmetric has tracked 25,793,330 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,825 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 342,802 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 341 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.